CapsoVision (CV) EPS (Basic) (2024 - 2026)

CapsoVision (CV) posted EPS (Basic) of -$0.3 for Q4 2025, down 75.69% sequentially from -$0.17 in Q3 2025, and up 86.89% YoY from -$0.16 in Q4 2024.

CapsoVision (CV) EPS (Basic) (2024 - 2026) Analysis & Trends

CapsoVision has reported EPS (Basic) for 2 years, with the latest figure at -$0.3 in Q4 2025.

Quarterly EPS (Basic) rose 86.89% year-over-year to -$0.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.0 (changed N/A YoY) and the FY2025 annual result came in at -$1.03, up 89.53% from the prior year.
EPS (Basic) retreated to -$0.3 in Q4 2025 per CV's latest filing, from -$0.17 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.17 in Q3 2025 and troughed at -$2.79 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.53
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	3.33
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.98
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.42
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.65
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	2.06
10	CapsoVision	295.13 Mn	286.05 Mn	1.87 Mn	-0.15

Download Data